Published in Infect Immun on October 01, 1993
Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev (2005) 6.02
BvgAS-mediated signal transduction: analysis of phase-locked regulatory mutants of Bordetella bronchiseptica in a rabbit model. Infect Immun (1994) 3.44
Integration of multiple domains in a two-component sensor protein: the Bordetella pertussis BvgAS phosphorelay. EMBO J (1996) 2.41
Human Bordetella bronchiseptica infection related to contact with infected animals: persistence of bacteria in host. J Clin Microbiol (1995) 1.84
Invasion and intracellular survival of Bordetella bronchiseptica in mouse dendritic cells. Infect Immun (1994) 1.23
A second two-component regulatory system of Bordetella bronchiseptica required for bacterial resistance to oxidative stress, production of acid phosphatase, and in vivo persistence. Infect Immun (1998) 1.11
Insertion sequences shared by Bordetella species and implications for the biological diagnosis of pertussis syndrome. Eur J Clin Microbiol Infect Dis (2012) 1.08
Replacement of adenylate cyclase toxin in a lineage of Bordetella bronchiseptica. J Bacteriol (2008) 1.03
Mechanisms involved in uptake of Bordetella bronchiseptica by mouse dendritic cells. Infect Immun (1994) 1.00
Role of the dermonecrotic toxin of Bordetella bronchiseptica in the pathogenesis of respiratory disease in swine. Infect Immun (2002) 1.00
Role of the type III secretion system in a hypervirulent lineage of Bordetella bronchiseptica. Infect Immun (2009) 0.97
Phase variation affects long-term survival of Bordetella bronchiseptica in professional phagocytes. Infect Immun (1997) 0.97
BvgAS is sufficient for activation of the Bordetella pertussis ptx locus in Escherichia coli. J Bacteriol (1995) 0.94
Bordetella bronchiseptica persists in the nasal cavities of mice and triggers early delivery of dendritic cells in the lymph nodes draining the lower and upper respiratory tract. Infect Immun (2003) 0.91
Phagosome acidification has opposite effects on intracellular survival of Bordetella pertussis and B. bronchiseptica. Infect Immun (2000) 0.89
The C-terminal domain is essential for protective activity of the Bordetella pertussis adenylate cyclase-hemolysin. Infect Immun (1995) 0.89
In vitro and in vivo characterization of a Bordetella bronchiseptica mutant strain with a deep rough lipopolysaccharide structure. Infect Immun (2002) 0.85
Bordetella pertussis risA, but not risS, is required for maximal expression of Bvg-repressed genes. Infect Immun (2005) 0.83
The Bordetella adenylate cyclase repeat-in-toxin (RTX) domain is immunodominant and elicits neutralizing antibodies. J Biol Chem (2014) 0.82
Bordetella bronchiseptica Pneumonia in an Extremely-Low-Birth-Weight Neonate. AJP Rep (2011) 0.75
A Case of Bordetella brochiseptica at a Military Medical Facility in Hawai'i: Phenotypic and Molecular Testing of an Uncommon Human Pathogen. Hawaii J Med Public Health (2015) 0.75
Bordetella Adenylate Cyclase-Hemolysin Toxins. Toxins (Basel) (2017) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81
A simple chemically defined medium for the production of phase I Bordetella pertussis. J Gen Microbiol (1970) 8.89
Biology of Bordetella bronchiseptica. Microbiol Rev (1980) 5.31
Genetic diversity and relationships in populations of Bordetella spp. J Bacteriol (1986) 4.48
Recognition of a bacterial adhesion by an integrin: macrophage CR3 (alpha M beta 2, CD11b/CD18) binds filamentous hemagglutinin of Bordetella pertussis. Cell (1990) 4.47
Phagocyte impotence caused by an invasive bacterial adenylate cyclase. Science (1982) 4.10
Bordetella parapertussis and Bordetella bronchiseptica contain transcriptionally silent pertussis toxin genes. J Bacteriol (1987) 3.44
Invasion of HeLa 229 cells by virulent Bordetella pertussis. Infect Immun (1989) 3.27
Molecular cloning and characterization of protective outer membrane protein P.69 from Bordetella pertussis. Proc Natl Acad Sci U S A (1989) 3.13
Human infections associated with Bordetella bronchiseptica. Clin Microbiol Rev (1991) 2.91
The bvgAS locus negatively controls motility and synthesis of flagella in Bordetella bronchiseptica. J Bacteriol (1992) 2.33
Evolutionary relationships in the genus Bordetella. Mol Microbiol (1987) 2.00
Comparative roles of the Arg-Gly-Asp sequence present in the Bordetella pertussis adhesins pertactin and filamentous hemagglutinin. Infect Immun (1992) 1.85
Pathogenesis of canine bordetellosis. J Infect Dis (1977) 1.74
Sequential activation and environmental regulation of virulence genes in Bordetella pertussis. EMBO J (1991) 1.73
Phase variants of Bordetella bronchiseptica arise by spontaneous deletions in the vir locus. Mol Microbiol (1989) 1.70
Bordetella pertussis adenylate cyclase. Purification, characterization, and radioimmunoassay. J Biol Chem (1986) 1.68
Evaluation of Bordetella bronchiseptica vaccines in specific-pathogen-free piglets with bacterial cell surface antigens in enzyme-linked immunosorbent assay. Infect Immun (1985) 1.64
Detection of Bordetella pertussis associated with the alveolar macrophages of children with human immunodeficiency virus infection. Infect Immun (1991) 1.62
Bordetella pertussis and Bordetella parapertussis: two immunologically distinct species. Infect Immun (1993) 1.62
Adenylate cyclase activity of Bordetella organisms. I. Its production in liquid medium. Microbiol Immunol (1980) 1.52
A vir-repressed gene of Bordetella pertussis is required for virulence. Infect Immun (1992) 1.47
Construction and characterization of Bordetella pertussis mutants lacking the vir-regulated P.69 outer membrane protein. Mol Microbiol (1991) 1.42
Deletions affecting hemolytic and toxin activities of Bordetella pertussis adenylate cyclase. Infect Immun (1990) 1.41
Growth and survival of Bordetella bronchiseptica in natural waters and in buffered saline without added nutrients. Appl Environ Microbiol (1991) 1.33
Intracellular survival of virulent Bordetella pertussis in human polymorphonuclear leukocytes. J Leukoc Biol (1991) 1.29
Cloning, nucleotide sequence and heterologous expression of the protective outer-membrane protein P.68 pertactin from Bordetella bronchiseptica. J Gen Microbiol (1992) 1.28
Nucleotide sequence homology to pertussis toxin gene in Bordetella bronchiseptica and Bordetella parapertussis. Infect Immun (1987) 1.26
Bordetella bronchiseptica pneumonia and bacteremia following bone marrow transplantation. J Clin Microbiol (1992) 1.24
Morphology of cells and hemagglutinogens of Bordetella species: resolution of substructural units in fimbriae of Bordetella pertussis. Infect Immun (1983) 1.19
Protective activity of Bordetella adenylate cyclase-hemolysin against bacterial colonization. Microb Pathog (1991) 1.12
Pasteurella multocida and Bordetella bronchiseptica infections in rabbits. J Clin Microbiol (1990) 1.08
Cytopathic effect of heat-labile toxin of Bordetella parapertussis on aortic smooth muscle cells from pigs or guinea pigs. Microbiol Immunol (1988) 1.04
Bordetella pertussis tracheal cytotoxin and other muramyl peptides: distinct structure-activity relationships for respiratory epithelial cytopathology. Proc Natl Acad Sci U S A (1993) 0.95
Long-lived respiratory immune response to filamentous hemagglutinin following Bordetella pertussis infection. Infect Immun (1993) 0.90
Isolation and characterization of mutant strains of Bordetella bronchiseptica lacking dermonecrotic toxin-producing ability. J Clin Microbiol (1988) 0.81
Epidemiological typing of Bordetella pertussis isolates: recommendations for a standard methodology. Eur J Clin Microbiol Infect Dis (2000) 3.09
Pertussis of adults and infants. Lancet Infect Dis (2002) 2.95
Bordetella pertussis induces apoptosis in macrophages: role of adenylate cyclase-hemolysin. Infect Immun (1993) 2.71
Nucleic Acid amplification tests for diagnosis of Bordetella infections. J Clin Microbiol (2005) 2.30
The adenylate cyclase toxin of Bordetella pertussis binds to target cells via the alpha(M)beta(2) integrin (CD11b/CD18). J Exp Med (2001) 2.12
Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years. J Clin Microbiol (2001) 2.02
A randomized double-blind trial comparing a two-component acellular to a whole-cell pertussis vaccine in Senegal. Vaccine (1997) 1.99
Human Bordetella bronchiseptica infection related to contact with infected animals: persistence of bacteria in host. J Clin Microbiol (1995) 1.84
First report and detailed characterization of B. pertussis isolates not expressing Pertussis Toxin or Pertactin. Vaccine (2009) 1.84
Bordetella pertussis adenylate cyclase. Purification, characterization, and radioimmunoassay. J Biol Chem (1986) 1.68
Epidemiology of pertussis in French hospitals in 1993 and 1994: thirty years after a routine use of vaccination. Pediatr Infect Dis J (1998) 1.63
Bordetella pertussis and Bordetella parapertussis: two immunologically distinct species. Infect Immun (1993) 1.62
Both adenylate cyclase and hemolytic activities are required by Bordetella pertussis to initiate infection. Microb Pathog (1992) 1.60
Comparison of polymerase chain reaction, culture, and western immunoblot serology for diagnosis of Bordetella pertussis infection. J Clin Microbiol (1993) 1.54
Expression and regulation of lactose genes carried by plasmids. J Bacteriol (1976) 1.53
Characterization of murine lung inflammation after infection with parental Bordetella pertussis and mutants deficient in adhesins or toxins. Infect Immun (1994) 1.50
Evaluation of the Andromas matrix-assisted laser desorption ionization-time of flight mass spectrometry system for identification of aerobically growing Gram-positive bacilli. J Clin Microbiol (2012) 1.45
Analysis of Bordetella pertussis populations in European countries with different vaccination policies. J Clin Microbiol (2005) 1.41
[The re-emergence of pertussis in Tunisia]. Med Mal Infect (2011) 1.40
Evolution of French Bordetella pertussis and Bordetella parapertussis isolates: increase of Bordetellae not expressing pertactin. Clin Microbiol Infect (2012) 1.37
Multiple regulation of the activity of adenylate cyclase in Escherichia coli. Mol Gen Genet (1982) 1.37
Intranasal murine model of Bordetella pertussis infection: II. Sequence variation and protection induced by a tricomponent acellular vaccine. Vaccine (1999) 1.33
Interactions of the Escherichia coli methionine repressor with the metF operator and with its corepressor, S-adenosylmethionine. J Biol Chem (1986) 1.32
Purification, location, and immunological characterization of the iron-regulated high-molecular-weight proteins of the highly pathogenic yersiniae. Infect Immun (1989) 1.25
Identification of the Escherichia coli cya gene product as authentic adenylate cyclase. J Mol Biol (1984) 1.25
Identification of AlcR, an AraC-type regulator of alcaligin siderophore synthesis in Bordetella bronchiseptica and Bordetella pertussis. J Bacteriol (1998) 1.24
Regulatory aspects of the cyclic AMP receptor protein in Escherichia coli K-12. Biochem Biophys Res Commun (1980) 1.24
Role of adenylate cyclase-hemolysin in alveolar macrophage apoptosis during Bordetella pertussis infection in vivo. Infect Immun (1998) 1.24
CyaC-mediated activation is important not only for toxic but also for protective activities of Bordetella pertussis adenylate cyclase-hemolysin. Infect Immun (1993) 1.22
Evidence for the presence of cAMP, cAMP receptor and transcription termination factor rho in different gram-negative bacteria. J Gen Microbiol (1985) 1.17
Role of adhesins and toxins in invasion of human tracheal epithelial cells by Bordetella pertussis. Infect Immun (2000) 1.16
Induction of macrophage apoptosis by Bordetella pertussis adenylate cyclase-hemolysin. FEMS Microbiol Lett (1995) 1.16
Isolation of Bordetella bronchiseptica from a patient with AIDS. Eur J Clin Microbiol Infect Dis (1993) 1.15
Bordetella holmesii isolated from a patient with sickle cell anemia: analysis and comparison with other Bordetella holmesii isolates. Clin Microbiol Infect (2000) 1.13
Antibodies against a fused 'lacZ-yeast mitochondrial intron' gene product allow identification of the mRNA maturase encoded by the fourth intron of the yeast cob-box gene. EMBO J (1984) 1.13
Long-term human serum antibody responses after immunization with whole-cell pertussis vaccine in France. Clin Diagn Lab Immunol (1996) 1.12
Enzyme immunoassays of adenosine cyclic 3',5'-monophosphate and guanosine cyclic 3',5'-monophosphate using acetylcholinesterase. Anal Chem (1989) 1.12
A phase variant of Bordetella pertussis with a mutation in a new locus involved in the regulation of pertussis toxin and adenylate cyclase toxin expression. J Bacteriol (1993) 1.09
Insertion sequences shared by Bordetella species and implications for the biological diagnosis of pertussis syndrome. Eur J Clin Microbiol Infect Dis (2012) 1.08
Recommendations are needed for adolescent and adult pertussis immunisation: rationale and strategies for consideration. Vaccine (2001) 1.08
Differential modulation of Bordetella pertussis virulence genes as evidenced by DNA microarray analysis. Mol Genet Genomics (2003) 1.06
Bordetella pertussis TonB, a Bvg-independent virulence determinant. Infect Immun (2000) 1.04
Influence of vaccination coverage on pertussis transmission in France. Lancet (1999) 1.03
Evaluation of an immunoglobulin G enzyme-linked immunosorbent assay for pertussis toxin and filamentous hemagglutinin in diagnosis of pertussis in Senegal. Clin Diagn Lab Immunol (1998) 1.03
Cloning and characterization of an Mn-containing superoxide dismutase (SodA) of Bordetella pertussis. J Bacteriol (1997) 1.01
Antigenic polymorphism of the lipopolysaccharides from human and animal isolates of Bordetella bronchiseptica. Microbiology (1997) 0.99
Detection of Bordetella bronchiseptica by the polymerase chain reaction. Res Microbiol (1999) 0.98
Multilocus sequence types of invasive Corynebacterium diphtheriae isolated in the Rio de Janeiro urban area, Brazil. Epidemiol Infect (2011) 0.96
Polymorphism of repeated regions of pertactin in Bordetella pertussis, Bordetella parapertussis, and Bordetella bronchiseptica. Infect Immun (2000) 0.95
Investigation on a pertussis outbreak in a military school: risk factors and approach to vaccine efficacy. Vaccine (2010) 0.93
In vivo and in vitro analysis of Bordetella pertussis catalase and Fe-superoxide dismutase mutants. FEMS Microbiol Lett (1996) 0.92
Analysis of Bordetella pertussis clinical isolates circulating in European countries during the period 1998-2012. Eur J Clin Microbiol Infect Dis (2014) 0.91
Cloning and sequence of the Bordetella bronchiseptica adenylate cyclase-hemolysin-encoding gene: comparison with the Bordetella pertussis gene. Gene (1995) 0.91
Intranasal inoculation of Bordetella bronchiseptica in mice induces long-lasting antibody and T-cell mediated immune responses. Scand J Immunol (1996) 0.91
Bordetella parapertussis isolates not expressing pertactin circulating in France. Clin Microbiol Infect (2011) 0.91
Release of outer membrane vesicles from Bordetella pertussis. Curr Microbiol (1999) 0.91
Adaptive responses of human monocytes infected by bordetella pertussis: the role of adenylate cyclase hemolysin. J Cell Physiol (2000) 0.90
The C-terminal domain is essential for protective activity of the Bordetella pertussis adenylate cyclase-hemolysin. Infect Immun (1995) 0.89
crpX mutants of Escherichia coli K12: specific regulatory effects of altered cyclic AMP receptor proteins. Mol Gen Genet (1982) 0.87
Variation in Bordetella bronchiseptica lipopolysaccharide during human infection. FEMS Microbiol Lett (1998) 0.87
Internalization of Bordetella pertussis adenylate cyclase-haemolysin into endocytic vesicles contributes to macrophage cytotoxicity. Cell Microbiol (2001) 0.86
Antibodies against synthetic oligopeptides allow identification of the mRNA-maturase encoded by the second intron of the yeast cob-box gene. EMBO J (1984) 0.86
Characterization and comparison of invasive Corynebacterium diphtheriae isolates from France and Poland. J Clin Microbiol (2011) 0.85
Enzyme and enzyme fragments purification by specific immunoadsorbents. Application to structural studies of aspartokinase I-homoserine dehydrogenase I of Escherichia coli. Eur J Biochem (1974) 0.85
Usefulness of pulsed-field gel electrophoresis in assessing nosocomial transmission of pertussis. Infect Control Hosp Epidemiol (1999) 0.85
Fimbrial typing of Bordetello pertussis isolates: agglutination with polyclonal and monoclonal antisera. J Clin Microbiol (2001) 0.84
A sustained increase in the endogenous level of cAMP reduces the retinoid concentration required for APL cell maturation to near physiological levels. Leukemia (1998) 0.83
[Epidemiological estimation of the effectiveness of the pertussis vaccination during outbreaks in a community. Les pédiatres et bactériologistes du réseau RENACOQ]. Arch Pediatr (1997) 0.82
Evolution of biosynthetic pathways: immunological approach. Proc Natl Acad Sci U S A (1975) 0.81
Rapid diagnosis of pertussis in young infants: comparison of culture, PCR, and infant's and mother's serology. Clin Diagn Lab Immunol (1997) 0.81
Transcription termination factor rho of Escherichia coli K-12: some regulatory aspects of its expression and activity. Biochimie (1983) 0.80
Pertussis incidence among adolescents and adults surveyed in general practices in the Paris area, France, May 2008 to March 2009. Euro Surveill (2011) 0.79
Dual infection with Bordetella pertussis and Mycoplasma pneumoniae in three infants: case reports. Infection (2011) 0.78
An unusual adenosine cyclic 3',5'-phosphate-dependent protein kinase from Dictyostelium discoideum. Biochemistry (1984) 0.78
The threonine-sensitive homoserine dehydrogenase and aspartokinase activities of Escherichia coli K12. Distribution and accessibility to antibodies of some epitopes of the bifunctional enzyme. Eur J Biochem (1975) 0.78
Characterization of a beta-galactosidase hybrid protein carrying the catalytic domain of Escherichia coli adenylate cyclase. Eur J Biochem (1986) 0.77
The utility of the PCR melting profile technique for typing Corynebacterium diphtheriae isolates. Lett Appl Microbiol (2014) 0.77
Inactivation and proteolysis of heat-sensitive adenylate kinase of Escherichia coli CR341 T28. J Biol Chem (1984) 0.77
Toxigenic Corynebacterium ulcerans in a fatal human case and her feline contacts, France, March 2014. Euro Surveill (2014) 0.77
[Awareness and adherence to Pertussis vaccination guidelines by occupational medicine physicians in Paris healthcare institution]. Med Mal Infect (2009) 0.76
Antibody-mediated inhibition of Bordetella pertussis adenylate cyclase-haemolysin-induced macrophage cytotoxicity is influenced by variations in the bacterial population. Microbiology (2014) 0.76
Cloning and expression in Escherichia coli of the TL-DNA gene 4 of Agrobacterium tumefaciens under the control of the PR promoter of bacteriophage lambda. Biochimie (1985) 0.75
[Pertussis: data collection and vaccinal strategy]. Med Mal Infect (2009) 0.75
[Positivity of ONPG test versus the presence of beta-galactosidase in Enterobacteriaceae and other Gram-negative bacilli (author's transl)]. Ann Microbiol (Paris) (1977) 0.75
[Genetic evolution under vaccine pressure: the Bordetella pertussis model]. Bull Soc Pathol Exot (2000) 0.75
[Bordetella bronchiseptica-associated acute chest syndrome in a child with sickle cell disease]. Arch Pediatr (2010) 0.75
Microbiological changes and diversity in autochthonous non-toxigenic Corynebacterium diphtheriae isolated in France. Clin Microbiol Infect (2013) 0.75
Immunological relatedness between beta-galactosidases of different bacterial origins. Mol Immunol (1979) 0.75
Purification and immunological characterization of bacterial and secreted adenylate cyclase of "Bordetella pertussis". Ann Sclavo Collana Monogr (1986) 0.75
Regulation of plasmid-encoded lactose genes in different gram-negative enterobacteriaceae. Plasmid (1980) 0.75
Diphtheria in the south of France, March 2011. Euro Surveill (2011) 0.75
An immunological determination of specific activities of enzymes: its use in quantification of cross reactivity between enzymes of different origins. Biochimie (1978) 0.75
[Action to be taken when facing one or more cases of whooping-cough]. Arch Pediatr (2005) 0.75